While, it is clear that grade II astrocytomas and oligodendrogliomas are very different from GBMs in terms of their molecular/genetic profiles, grade II gliomas are benign brain tumors and were selected as a reference to analyze GBM-specific TF networks. The gene discussed is TF; the disease is glioma.